STADA Pharmaceuticals Australia Pty Ltd is a speciality pharmaceutical company focusing on infusion therapies in neurology in Australia and New Zealand. We are part of a global pharmaceutical group of companies founded 125 years ago, with offices in more than 30 countries and a presence in approximately 120 countries. STADA Australia is dedicated to supplying innovative products for chronic and serious medical conditions, especially the treatment of Parkinson’s disease. We understand the importance of partnering with healthcare professionals to improve the quality of life for patients and support carers through the provision of specialty products and services. STADA supplies MOVAPO® (apomorphine hydrochloride) drug therapy in Australia and New Zealand.

https://www.stada.com.au/​